Patel Sujal M — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Patel Sujal M is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $136K.
Profile
Sujal M Patel is the CEO and a director of Nautilus Biotechnology, Inc., a company focused on advancing proteomics technology. He has played a significant role in the development of the company's platform aimed at improving human health through proteome analysis.
Role
CEO, President, and Secretary, Director, 10% Owner
Sujal M Patel is the CEO and a director of Nautilus Biotechnology, Inc., a company focused on advancing proteomics technology. He has played a significant role in the development of the company's platform aimed at improving human health through proteome analysis.…
Has Patel Sujal M been buying or selling stock?
Recorded transactions: 2 open-market purchases ($136K) and 0 open-market sales () across all tracked filings.
Where can I see all of Patel Sujal M's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
